Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreaticoduodenectomy | 30 | 2024 | 508 | 4.100 |
Why?
|
Pancreatectomy | 24 | 2023 | 810 | 4.050 |
Why?
|
General Surgery | 17 | 2024 | 1677 | 2.700 |
Why?
|
Pancreatic Fistula | 19 | 2022 | 148 | 2.450 |
Why?
|
Internship and Residency | 23 | 2024 | 5865 | 2.270 |
Why?
|
Pancreatic Neoplasms | 27 | 2024 | 5349 | 2.030 |
Why?
|
Pressure Ulcer | 2 | 2019 | 156 | 1.170 |
Why?
|
Cultural Competency | 5 | 2024 | 297 | 1.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 8 | 2024 | 1724 | 0.970 |
Why?
|
Patient Discharge | 4 | 2023 | 3433 | 0.970 |
Why?
|
Curriculum | 14 | 2024 | 3717 | 0.940 |
Why?
|
Pancreatitis, Chronic | 3 | 2023 | 281 | 0.880 |
Why?
|
Audiovisual Aids | 1 | 2024 | 99 | 0.880 |
Why?
|
Clinical Competence | 13 | 2024 | 4775 | 0.840 |
Why?
|
Translating | 1 | 2023 | 143 | 0.820 |
Why?
|
Comprehension | 2 | 2018 | 619 | 0.800 |
Why?
|
Clinical Clerkship | 2 | 2019 | 563 | 0.790 |
Why?
|
Duodenal Neoplasms | 4 | 2024 | 115 | 0.730 |
Why?
|
Digestive System Surgical Procedures | 5 | 2020 | 575 | 0.720 |
Why?
|
Informed Consent | 2 | 2024 | 1003 | 0.710 |
Why?
|
Hostility | 1 | 2020 | 183 | 0.660 |
Why?
|
Education, Medical, Undergraduate | 2 | 2019 | 1066 | 0.640 |
Why?
|
Internet | 5 | 2020 | 3082 | 0.630 |
Why?
|
Common Bile Duct Neoplasms | 4 | 2024 | 120 | 0.610 |
Why?
|
Ampulla of Vater | 4 | 2024 | 149 | 0.600 |
Why?
|
Pancreas | 4 | 2023 | 1676 | 0.580 |
Why?
|
Group Processes | 1 | 2018 | 226 | 0.570 |
Why?
|
Pancreaticojejunostomy | 3 | 2013 | 26 | 0.570 |
Why?
|
Rehabilitation Centers | 1 | 2018 | 247 | 0.560 |
Why?
|
Postoperative Complications | 25 | 2023 | 15637 | 0.560 |
Why?
|
Faculty, Medical | 3 | 2020 | 1192 | 0.550 |
Why?
|
Students, Medical | 3 | 2020 | 1927 | 0.550 |
Why?
|
Judgment | 1 | 2018 | 273 | 0.540 |
Why?
|
Teaching Materials | 1 | 2016 | 84 | 0.530 |
Why?
|
Patient Education as Topic | 2 | 2024 | 2307 | 0.520 |
Why?
|
Competency-Based Education | 1 | 2017 | 218 | 0.520 |
Why?
|
Decision Support Techniques | 6 | 2018 | 1996 | 0.510 |
Why?
|
Adenocarcinoma | 11 | 2024 | 6313 | 0.510 |
Why?
|
Bullying | 1 | 2018 | 230 | 0.500 |
Why?
|
Medicine | 1 | 2023 | 942 | 0.500 |
Why?
|
Language | 2 | 2022 | 1532 | 0.500 |
Why?
|
Electronic Mail | 1 | 2016 | 213 | 0.480 |
Why?
|
Consumer Health Information | 1 | 2016 | 210 | 0.450 |
Why?
|
Blood Loss, Surgical | 7 | 2021 | 653 | 0.450 |
Why?
|
Workplace | 1 | 2020 | 857 | 0.450 |
Why?
|
Propensity Score | 8 | 2023 | 1907 | 0.440 |
Why?
|
Patient Readmission | 6 | 2023 | 3261 | 0.420 |
Why?
|
Learning | 2 | 2020 | 1739 | 0.410 |
Why?
|
Burnout, Professional | 1 | 2021 | 701 | 0.400 |
Why?
|
Quality Indicators, Health Care | 5 | 2016 | 1797 | 0.400 |
Why?
|
Teaching | 2 | 2016 | 1168 | 0.390 |
Why?
|
Drainage | 4 | 2021 | 1161 | 0.380 |
Why?
|
Self Concept | 1 | 2017 | 1041 | 0.380 |
Why?
|
Retrospective Studies | 46 | 2024 | 80168 | 0.380 |
Why?
|
Geriatric Assessment | 1 | 2018 | 1404 | 0.370 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1159 | 0.370 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2014 | 496 | 0.360 |
Why?
|
Humans | 110 | 2024 | 758406 | 0.360 |
Why?
|
Physician-Patient Relations | 1 | 2023 | 3242 | 0.350 |
Why?
|
Cost of Illness | 3 | 2017 | 1936 | 0.350 |
Why?
|
Education, Medical, Graduate | 9 | 2024 | 2359 | 0.340 |
Why?
|
Fatigue | 1 | 2017 | 1542 | 0.340 |
Why?
|
Stents | 5 | 2018 | 3162 | 0.340 |
Why?
|
Communication Barriers | 2 | 2023 | 413 | 0.330 |
Why?
|
Surgical Wound Dehiscence | 1 | 2010 | 216 | 0.330 |
Why?
|
Interpersonal Relations | 1 | 2016 | 1433 | 0.330 |
Why?
|
Risk Assessment | 21 | 2021 | 23884 | 0.320 |
Why?
|
Tomography, Spiral Computed | 1 | 2010 | 273 | 0.310 |
Why?
|
Attitude of Health Personnel | 3 | 2019 | 3867 | 0.310 |
Why?
|
Biliary Tract Neoplasms | 1 | 2010 | 184 | 0.300 |
Why?
|
Surgical Wound Infection | 2 | 2018 | 1526 | 0.290 |
Why?
|
Female | 66 | 2024 | 390323 | 0.290 |
Why?
|
Risk Factors | 30 | 2023 | 73809 | 0.270 |
Why?
|
Male | 64 | 2024 | 358747 | 0.270 |
Why?
|
Hospital Costs | 4 | 2018 | 960 | 0.270 |
Why?
|
Middle Aged | 51 | 2024 | 219568 | 0.260 |
Why?
|
Quality Improvement | 3 | 2020 | 3806 | 0.260 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2024 | 3992 | 0.240 |
Why?
|
Boston | 7 | 2020 | 9304 | 0.240 |
Why?
|
Cholestasis | 2 | 2019 | 377 | 0.240 |
Why?
|
Caregivers | 1 | 2017 | 2225 | 0.240 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2017 | 2159 | 0.230 |
Why?
|
Aged | 46 | 2024 | 168218 | 0.230 |
Why?
|
Inpatients | 1 | 2016 | 2551 | 0.230 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 3 | 2023 | 506 | 0.230 |
Why?
|
Schools, Medical | 2 | 2021 | 877 | 0.230 |
Why?
|
Salvage Therapy | 1 | 2010 | 1268 | 0.230 |
Why?
|
Education, Medical, Continuing | 2 | 2021 | 827 | 0.220 |
Why?
|
Academic Medical Centers | 3 | 2020 | 2751 | 0.220 |
Why?
|
Emotional Intelligence | 2 | 2014 | 135 | 0.220 |
Why?
|
Massachusetts | 6 | 2021 | 8823 | 0.210 |
Why?
|
Surgical Procedures, Operative | 2 | 2024 | 1911 | 0.200 |
Why?
|
Treatment Outcome | 24 | 2023 | 64378 | 0.200 |
Why?
|
Cholangiocarcinoma | 2 | 2024 | 550 | 0.200 |
Why?
|
Neoplasm Staging | 7 | 2020 | 11152 | 0.190 |
Why?
|
Qualitative Research | 3 | 2023 | 2976 | 0.190 |
Why?
|
Deoxycytidine | 2 | 2019 | 870 | 0.190 |
Why?
|
Vascular Surgical Procedures | 1 | 2010 | 1470 | 0.190 |
Why?
|
Time Factors | 17 | 2018 | 39872 | 0.190 |
Why?
|
Adult | 32 | 2024 | 219935 | 0.180 |
Why?
|
Analgesics, Opioid | 3 | 2023 | 3765 | 0.180 |
Why?
|
Writing | 1 | 2022 | 199 | 0.180 |
Why?
|
Personnel Selection | 1 | 2022 | 194 | 0.170 |
Why?
|
Digestive System Neoplasms | 1 | 2020 | 81 | 0.170 |
Why?
|
Ethics, Professional | 1 | 2020 | 100 | 0.170 |
Why?
|
Learning Curve | 2 | 2021 | 231 | 0.170 |
Why?
|
Survival Rate | 10 | 2024 | 12721 | 0.170 |
Why?
|
Faculty | 2 | 2020 | 383 | 0.170 |
Why?
|
Lymph Nodes | 2 | 2022 | 3485 | 0.170 |
Why?
|
Endosonography | 1 | 2023 | 607 | 0.160 |
Why?
|
Biliary Tract Surgical Procedures | 2 | 2016 | 45 | 0.160 |
Why?
|
United States | 21 | 2024 | 72136 | 0.160 |
Why?
|
Multivariate Analysis | 9 | 2016 | 12096 | 0.160 |
Why?
|
Fellowships and Scholarships | 2 | 2018 | 1115 | 0.160 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2048 | 0.150 |
Why?
|
Abdominal Muscles | 1 | 2019 | 169 | 0.150 |
Why?
|
Focus Groups | 3 | 2020 | 1384 | 0.150 |
Why?
|
Octreotide | 2 | 2018 | 153 | 0.150 |
Why?
|
Length of Stay | 9 | 2021 | 6439 | 0.140 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2017 | 26 | 0.140 |
Why?
|
Laparoscopy | 4 | 2017 | 2147 | 0.140 |
Why?
|
Infusion Pumps, Implantable | 1 | 2017 | 158 | 0.140 |
Why?
|
Gallstones | 1 | 2019 | 283 | 0.130 |
Why?
|
Perception | 2 | 2020 | 1197 | 0.130 |
Why?
|
Interviews as Topic | 1 | 2023 | 2676 | 0.130 |
Why?
|
Organizations, Nonprofit | 1 | 2016 | 104 | 0.130 |
Why?
|
Government | 1 | 2016 | 161 | 0.130 |
Why?
|
Palliative Care | 2 | 2021 | 3570 | 0.120 |
Why?
|
Needs Assessment | 3 | 2019 | 1141 | 0.120 |
Why?
|
Nomograms | 2 | 2020 | 237 | 0.120 |
Why?
|
Gastric Bypass | 1 | 2023 | 817 | 0.120 |
Why?
|
Radiosurgery | 2 | 2017 | 1342 | 0.120 |
Why?
|
Bile Duct Diseases | 1 | 2015 | 97 | 0.120 |
Why?
|
Celiac Artery | 1 | 2015 | 65 | 0.120 |
Why?
|
Universities | 1 | 2020 | 993 | 0.120 |
Why?
|
Fluorouracil | 1 | 2019 | 1631 | 0.120 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15225 | 0.120 |
Why?
|
Bile Ducts | 1 | 2015 | 282 | 0.110 |
Why?
|
Population Growth | 1 | 2013 | 50 | 0.110 |
Why?
|
Ownership | 1 | 2016 | 339 | 0.110 |
Why?
|
Constriction, Pathologic | 2 | 2015 | 1097 | 0.110 |
Why?
|
Mass Media | 1 | 2016 | 301 | 0.110 |
Why?
|
Pancreatic Cyst | 1 | 2017 | 367 | 0.110 |
Why?
|
Health Expenditures | 2 | 2016 | 2347 | 0.110 |
Why?
|
Bariatric Surgery | 1 | 2023 | 986 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2024 | 3527 | 0.110 |
Why?
|
Delphi Technique | 1 | 2016 | 829 | 0.110 |
Why?
|
Paraganglioma | 1 | 2014 | 142 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 5 | 2018 | 6493 | 0.110 |
Why?
|
Cohort Studies | 6 | 2024 | 41256 | 0.110 |
Why?
|
Organizational Culture | 1 | 2016 | 506 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 413 | 0.100 |
Why?
|
Severity of Illness Index | 6 | 2017 | 15785 | 0.100 |
Why?
|
Lipoma | 1 | 2014 | 292 | 0.100 |
Why?
|
Hypotension | 1 | 2018 | 879 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 2023 | 1277 | 0.100 |
Why?
|
Hamartoma | 1 | 2014 | 235 | 0.100 |
Why?
|
Complementary Therapies | 1 | 2016 | 486 | 0.100 |
Why?
|
Iohexol | 1 | 2013 | 204 | 0.100 |
Why?
|
Nerve Block | 1 | 2019 | 688 | 0.100 |
Why?
|
Pandemics | 2 | 2023 | 8611 | 0.100 |
Why?
|
Pancreatitis | 1 | 2019 | 1098 | 0.100 |
Why?
|
Patient Selection | 3 | 2014 | 4244 | 0.100 |
Why?
|
Neoadjuvant Therapy | 3 | 2018 | 2821 | 0.100 |
Why?
|
Incidence | 5 | 2021 | 21272 | 0.090 |
Why?
|
Pain | 2 | 2023 | 5065 | 0.090 |
Why?
|
Prospective Studies | 5 | 2023 | 54137 | 0.090 |
Why?
|
Accreditation | 1 | 2014 | 473 | 0.090 |
Why?
|
Florida | 3 | 2017 | 431 | 0.090 |
Why?
|
Anastomosis, Surgical | 3 | 2021 | 983 | 0.090 |
Why?
|
Computer-Assisted Instruction | 1 | 2014 | 362 | 0.090 |
Why?
|
Appendectomy | 1 | 2014 | 431 | 0.090 |
Why?
|
Pathology, Clinical | 1 | 2014 | 375 | 0.090 |
Why?
|
Comorbidity | 2 | 2023 | 10495 | 0.090 |
Why?
|
Accidental Falls | 1 | 2018 | 1056 | 0.090 |
Why?
|
Workload | 1 | 2016 | 847 | 0.090 |
Why?
|
Education, Distance | 1 | 2014 | 259 | 0.090 |
Why?
|
Employment | 1 | 2017 | 1112 | 0.090 |
Why?
|
Morbidity | 3 | 2023 | 1754 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2292 | 0.090 |
Why?
|
Educational Measurement | 1 | 2017 | 1248 | 0.090 |
Why?
|
Social Behavior | 1 | 2016 | 1131 | 0.090 |
Why?
|
Gastroenterology | 1 | 2016 | 571 | 0.090 |
Why?
|
Chi-Square Distribution | 4 | 2019 | 3425 | 0.090 |
Why?
|
Biliary Fistula | 1 | 2009 | 37 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1263 | 0.080 |
Why?
|
Databases, Factual | 7 | 2019 | 7980 | 0.080 |
Why?
|
Catheter Ablation | 1 | 2023 | 2740 | 0.080 |
Why?
|
Leiomyoma | 1 | 2014 | 654 | 0.080 |
Why?
|
Unnecessary Procedures | 1 | 2013 | 411 | 0.080 |
Why?
|
Activities of Daily Living | 1 | 2018 | 2414 | 0.080 |
Why?
|
Bronchial Fistula | 1 | 2009 | 83 | 0.080 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2011 | 345 | 0.080 |
Why?
|
Odds Ratio | 4 | 2016 | 9650 | 0.080 |
Why?
|
Patient Care Planning | 1 | 2014 | 907 | 0.080 |
Why?
|
Medical Records | 1 | 2014 | 1406 | 0.080 |
Why?
|
Intraoperative Care | 1 | 2012 | 766 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2142 | 0.080 |
Why?
|
Cause of Death | 2 | 2017 | 3675 | 0.080 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2014 | 615 | 0.080 |
Why?
|
Bile Duct Neoplasms | 2 | 2024 | 602 | 0.080 |
Why?
|
Pancreatic Ducts | 1 | 2010 | 329 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1721 | 0.080 |
Why?
|
Radiographic Image Enhancement | 1 | 2013 | 875 | 0.080 |
Why?
|
Neuroendocrine Tumors | 1 | 2014 | 650 | 0.080 |
Why?
|
Aged, 80 and over | 13 | 2022 | 58683 | 0.080 |
Why?
|
Information Dissemination | 1 | 2016 | 1129 | 0.070 |
Why?
|
Logistic Models | 7 | 2017 | 13276 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2018 | 5199 | 0.070 |
Why?
|
Appendicitis | 1 | 2014 | 674 | 0.070 |
Why?
|
Perioperative Care | 2 | 2012 | 1028 | 0.070 |
Why?
|
Hospital Mortality | 3 | 2016 | 5272 | 0.070 |
Why?
|
Critical Pathways | 1 | 2011 | 473 | 0.070 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3617 | 0.070 |
Why?
|
Reoperation | 5 | 2017 | 4282 | 0.070 |
Why?
|
Thoracic Injuries | 1 | 2009 | 278 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4313 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3714 | 0.070 |
Why?
|
Multiple Trauma | 1 | 2009 | 369 | 0.070 |
Why?
|
Communication | 1 | 2021 | 3846 | 0.070 |
Why?
|
Regression Analysis | 2 | 2016 | 6354 | 0.070 |
Why?
|
Abdominal Injuries | 1 | 2009 | 359 | 0.070 |
Why?
|
Postoperative Care | 1 | 2013 | 1471 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8530 | 0.070 |
Why?
|
Endoscopy | 1 | 2016 | 1834 | 0.070 |
Why?
|
Ultrasonography | 2 | 2018 | 5952 | 0.070 |
Why?
|
MutS Homolog 2 Protein | 1 | 2006 | 195 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 2 | 2007 | 2800 | 0.070 |
Why?
|
Parenteral Nutrition | 1 | 2010 | 656 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2020 | 4317 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 7985 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20500 | 0.060 |
Why?
|
RNA Stability | 1 | 2007 | 331 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3446 | 0.060 |
Why?
|
Population Surveillance | 1 | 2015 | 2606 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7378 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2013 | 1956 | 0.060 |
Why?
|
Health Care Reform | 1 | 2013 | 1245 | 0.060 |
Why?
|
Blood Vessels | 1 | 2010 | 1112 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2024 | 39059 | 0.060 |
Why?
|
Adenoma | 1 | 2014 | 2148 | 0.060 |
Why?
|
Wounds, Gunshot | 1 | 2009 | 581 | 0.060 |
Why?
|
Decision Making | 1 | 2017 | 3915 | 0.060 |
Why?
|
Risk Adjustment | 2 | 2017 | 600 | 0.050 |
Why?
|
Drug Administration Schedule | 3 | 2019 | 4839 | 0.050 |
Why?
|
Survival Analysis | 2 | 2015 | 10112 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
Colorectal Neoplasms | 3 | 2007 | 6852 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2167 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3418 | 0.050 |
Why?
|
Efficiency | 2 | 2018 | 477 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5331 | 0.050 |
Why?
|
Proportional Hazards Models | 4 | 2020 | 12440 | 0.050 |
Why?
|
Health Care Costs | 1 | 2015 | 3245 | 0.050 |
Why?
|
Ambulatory Care | 1 | 2013 | 2768 | 0.050 |
Why?
|
Obesity | 1 | 2023 | 12870 | 0.050 |
Why?
|
Health Policy | 1 | 2013 | 2677 | 0.050 |
Why?
|
Young Adult | 6 | 2017 | 58808 | 0.050 |
Why?
|
Gene Deletion | 1 | 2007 | 2666 | 0.040 |
Why?
|
Hepatectomy | 1 | 2023 | 559 | 0.040 |
Why?
|
Pediatrics | 1 | 2014 | 3587 | 0.040 |
Why?
|
Professional Misconduct | 1 | 2019 | 73 | 0.040 |
Why?
|
Gastrectomy | 1 | 2023 | 670 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1705 | 0.040 |
Why?
|
Adolescent | 7 | 2017 | 87892 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3364 | 0.040 |
Why?
|
Gold Radioisotopes | 1 | 1997 | 3 | 0.040 |
Why?
|
Germ-Line Mutation | 1 | 2006 | 1840 | 0.040 |
Why?
|
Blood Transfusion | 2 | 2017 | 1321 | 0.040 |
Why?
|
Health Care Surveys | 2 | 2016 | 2432 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13591 | 0.040 |
Why?
|
Cooperative Behavior | 2 | 2015 | 1501 | 0.040 |
Why?
|
Patients | 1 | 2023 | 904 | 0.030 |
Why?
|
Cholecystectomy | 1 | 2019 | 406 | 0.030 |
Why?
|
Physicians | 1 | 2014 | 4580 | 0.030 |
Why?
|
Prognosis | 4 | 2024 | 29557 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3563 | 0.030 |
Why?
|
Acute Disease | 2 | 2019 | 7225 | 0.030 |
Why?
|
Base Pair Mismatch | 2 | 2006 | 92 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25956 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 729 | 0.030 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2019 | 638 | 0.030 |
Why?
|
Italy | 1 | 2017 | 839 | 0.030 |
Why?
|
Selection Bias | 1 | 2017 | 357 | 0.030 |
Why?
|
Bupivacaine | 1 | 2019 | 413 | 0.030 |
Why?
|
Quality of Life | 1 | 2017 | 13285 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2020 | 799 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2019 | 578 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 596 | 0.030 |
Why?
|
Internal Medicine | 1 | 2022 | 1048 | 0.030 |
Why?
|
Advisory Committees | 1 | 2018 | 785 | 0.030 |
Why?
|
Problem-Based Learning | 1 | 2018 | 352 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2210 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2020 | 1303 | 0.030 |
Why?
|
Self Efficacy | 1 | 2018 | 632 | 0.030 |
Why?
|
New Zealand | 1 | 2014 | 352 | 0.030 |
Why?
|
Linear Models | 2 | 2014 | 5862 | 0.030 |
Why?
|
Health Care Rationing | 1 | 2016 | 434 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2006 | 4938 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2850 | 0.030 |
Why?
|
Gastrointestinal Agents | 1 | 2018 | 508 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2019 | 785 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2007 | 8506 | 0.030 |
Why?
|
Postoperative Period | 1 | 2017 | 1812 | 0.030 |
Why?
|
Models, Economic | 1 | 2016 | 715 | 0.030 |
Why?
|
Psychological Tests | 1 | 2014 | 639 | 0.030 |
Why?
|
Philadelphia | 1 | 2012 | 265 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7403 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2006 | 5786 | 0.020 |
Why?
|
Reference Values | 1 | 2019 | 4919 | 0.020 |
Why?
|
Patient Preference | 1 | 2019 | 921 | 0.020 |
Why?
|
CA-19-9 Antigen | 1 | 2011 | 106 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2017 | 801 | 0.020 |
Why?
|
North America | 1 | 2014 | 1276 | 0.020 |
Why?
|
Publishing | 1 | 2018 | 833 | 0.020 |
Why?
|
Australia | 1 | 2014 | 1276 | 0.020 |
Why?
|
Blood Volume | 1 | 2011 | 550 | 0.020 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2010 | 100 | 0.020 |
Why?
|
Brachytherapy | 1 | 1997 | 1236 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1673 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2943 | 0.020 |
Why?
|
Program Evaluation | 1 | 2018 | 2492 | 0.020 |
Why?
|
Contusions | 1 | 2009 | 79 | 0.020 |
Why?
|
Radiotherapy Dosage | 2 | 2011 | 2896 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1402 | 0.020 |
Why?
|
Fear | 1 | 2017 | 1462 | 0.020 |
Why?
|
Pain Measurement | 1 | 2019 | 3527 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 22032 | 0.020 |
Why?
|
Diaphragm | 1 | 2009 | 351 | 0.020 |
Why?
|
International Cooperation | 1 | 2014 | 1430 | 0.020 |
Why?
|
Emergencies | 1 | 2014 | 1209 | 0.020 |
Why?
|
Esophagogastric Junction | 1 | 2009 | 341 | 0.020 |
Why?
|
Recurrence | 2 | 2019 | 8426 | 0.020 |
Why?
|
Politics | 1 | 2013 | 815 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10748 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4158 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1214 | 0.020 |
Why?
|
Tracheostomy | 1 | 2009 | 425 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2007 | 514 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3891 | 0.020 |
Why?
|
Mutation | 2 | 2006 | 29915 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2007 | 749 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 2007 | 895 | 0.010 |
Why?
|
Algorithms | 2 | 2015 | 13961 | 0.010 |
Why?
|
Microsatellite Instability | 1 | 2007 | 715 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10652 | 0.010 |
Why?
|
Medical Errors | 1 | 2011 | 1255 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 11709 | 0.010 |
Why?
|
Consensus | 1 | 2012 | 3099 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 785 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2006 | 1539 | 0.010 |
Why?
|
Anxiety | 1 | 2017 | 4539 | 0.010 |
Why?
|
Patient-Centered Care | 1 | 2012 | 1415 | 0.010 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2011 | 1659 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2013 | 20055 | 0.010 |
Why?
|
Education, Medical | 1 | 2013 | 1725 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2057 | 0.010 |
Why?
|
Insurance, Health | 1 | 2014 | 2495 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29742 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2009 | 1688 | 0.010 |
Why?
|
Collagen | 1 | 2009 | 2635 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2007 | 12759 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2006 | 1745 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22029 | 0.010 |
Why?
|
Contrast Media | 1 | 2013 | 5298 | 0.010 |
Why?
|
Medicare | 1 | 2018 | 6741 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2007 | 16886 | 0.010 |
Why?
|
Critical Care | 1 | 2011 | 2692 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2009 | 2618 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4106 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4567 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14641 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5031 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 1997 | 228 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 6068 | 0.010 |
Why?
|
RNA Interference | 1 | 2005 | 2836 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2013 | 4761 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9460 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2006 | 2895 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18358 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2012 | 5404 | 0.010 |
Why?
|
Parotid Neoplasms | 1 | 1976 | 157 | 0.010 |
Why?
|
Disease Progression | 1 | 2011 | 13468 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 1997 | 11336 | 0.010 |
Why?
|
Child | 2 | 2022 | 79818 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 12436 | 0.010 |
Why?
|
Liver | 1 | 2009 | 7502 | 0.010 |
Why?
|
Genetic Testing | 1 | 2006 | 3530 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 17617 | 0.010 |
Why?
|
Mass Screening | 1 | 2006 | 5427 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10416 | 0.010 |
Why?
|
Apoptosis | 1 | 2005 | 9468 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1997 | 9273 | 0.000 |
Why?
|
Facial Nerve Injuries | 1 | 1976 | 64 | 0.000 |
Why?
|
Iatrogenic Disease | 1 | 1976 | 538 | 0.000 |
Why?
|